H. Myrick

Treatment of Alcohol-Related Disorders
20210 citationsauthor #3
Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.
201757 citationsauthor #19
Randomized Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results from STimulant Reduction Intervention using Dosed Exercise (CTN-0037; STRIDE)
20175 citationsauthor #23
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
201780 citationsauthor #6
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
201735 citationsauthor #6
Regional Brain Activity in Abstinent Methamphetamine Dependent Males Following Cue Exposure.
201621 citationsauthor #2
Suicide-specific Safety in the Inpatient Psychiatric Unit
201532 citationsauthor #2
The Use of Divalproex in the Treatment of Addictive Disorders
20157 citationsauthor #1
Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes.
20157 citationsauthor #6
Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy and Their Combination in OEF/OIF with PTSD
20150 citationsauthor #15
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
201456 citationsauthor #6
Medications for use in alcohol rehabilitation
20143 citationsauthor #1
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
20140 citationsauthor #6
Treatment of Alcohol Intoxication and Alcohol Withdrawal
20141 citationsauthor #1
Variation in SLC1A1 is related to combat-related posttraumatic stress disorder.
201411 citationsauthor #5
The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues.
201480 citationsauthor #3
Brain activation to cocaine cues and motivation/treatment status
201466 citationsauthor #3
Delivery of Evidence-Based Psychotherapy via Video Telehealth
2013204 citationsauthor #8
Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse.
201353 citationsauthor #2
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review
2013492 citationsauthor #3
Interacting Effects of Naltrexone and OPRM1 and DAT1 Variation on the Neural Response to Alcohol Cues
201389 citationsauthor #7
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics
201332 citationsauthor #6
Computer simulation games as an adjunct for treatment in male veterans with alcohol use disorder.
201334 citationsauthor #3
Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.
201333 citationsauthor #2
Task-Specific Self-Efficacy for Relapse Prevention Questionnaire
20130 citationsauthor #3
Health service utilization before and after evidence-based treatment for PTSD.
2013100 citationsauthor #6
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
201261 citationsauthor #4
Prolonged exposure therapy for combat-related posttraumatic stress disorder: comparing outcomes for veterans of different wars.
201286 citationsauthor #6
Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence.
201213 citationsauthor #3
A Pilot Trial of Neuropsychological Evaluations Conducted via Telemedicine in the Veterans Health Administration
201234 citationsauthor #4
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers
2011127 citationsauthor #4
Prolonged exposure therapy for combat-related posttraumatic stress disorder: an examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq.
2011200 citationsauthor #4
Gabapentin combined with naltrexone for the treatment of alcohol dependence.
2011128 citationsauthor #2
Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
201112 citationsauthor #7
Stability of fMRI striatal response to alcohol cues: A hierarchical linear modeling approach
201178 citationsauthor #6
Neuropeptide Y rs16147 single nucleotide polymorphism is associated with heavy drinking and severity of alcohol dependence
20101 citationsauthor #5
The Effect of Aripiprazole on Cue-Induced Brain Activation and Drinking Parameters in Alcoholics
201071 citationsauthor #1
Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence: Relationship to Alcohol Withdrawal Symptoms
200977 citationsauthor #2
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
2009182 citationsauthor #1
Combat Posttraumatic Stress Disorder, Substance Use Disorders, and Traumatic Brain Injury
200928 citationsauthor #6
Advances in Substance Abuse Treatment
20090 citationsauthor #2
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.
2008249 citationsauthor #1
FUNDING WATCH
20080 citationsauthor #1
FUNDING WATCH
20080 citationsauthor #1
PFIQ Scores Improve after Prolapse Surgery in Women With Depressive Symptoms but Remain Higher than in Women Without Depressive Symptoms
20081 citationsauthor #3
FUNDING WATCH #14
20080 citationsauthor #1
Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.
200866 citationsauthor #3
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
200737 citationsauthor #2
Impact of Lifetime Alcohol Quit Attempts and Medicated Detoxifications on Time to Relapse During an Index Alcohol Detoxification
20075 citationsauthor #2
Is cocaine desire reduced by N-acetylcysteine?
2007216 citationsauthor #2
FUNDING WATCH
20070 citationsauthor #1
A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
200772 citationsauthor #1
FUNDING WATCH
20070 citationsauthor #1
FUNDING WATCH
20060 citationsauthor #1
FUNDING WATCH
20060 citationsauthor #1
Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal.
200632 citationsauthor #2
Acamprosate: a new tool in the battle against alcohol dependence
200610 citationsauthor #2
The Diagnosis and Treatment of Substance Abuse/ Dependence and Co-Occurring Social Anxiety Disorder
20061 citationsauthor #2
FUNDING WATCH
20060 citationsauthor #1
Risk factors for delirium tremens: a retrospective chart review.
200652 citationsauthor #2
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.
2006174 citationsauthor #4
FUNDING WATCH
20060 citationsauthor #1
Editorial Review: Current Review of the Comorbidity of Affective, Anxiety, and Substance Use Disorders
20068 citationsauthor #1
Telehealth service delivery for persons with alcoholism
200514 citationsauthor #3
Increased fasting plasma ghrelin levels during alcohol abstinence.
2005120 citationsauthor #7
Naltrexone Combined With Either Cognitive Behavioral or Motivational Enhancement Therapy for Alcohol Dependence
2005123 citationsauthor #5
Health service use among persons with comorbid bipolar and substance use disorders.
200528 citationsauthor #4
FUNCTIONAL NEUROANATOMY OF SUBCOMPONENT COGNITIVE PROCESSES INVOLVED IN VERBAL WORKING MEMORY
200535 citationsauthor #5
Novel anticonvulsants in the treatment of alcoholism
200559 citationsauthor #2
FUNDING WATCH
20050 citationsauthor #1
Telehealth service delivery for persons with alcoholism.
200586 citationsauthor #3
A Retrospective Chart Review Comparing Tiagabine and Benzodiazepines for the Treatment of Alcohol Withdrawal
200524 citationsauthor #1
FUNDING WATCH
20050 citationsauthor #1
Comorbid Anxiety and Substance Use Disorders
20051 citationsauthor #1
Safety and efficacy of GABAergic medications for treating alcoholism.
200560 citationsauthor #5
Funding Watch
20050 citationsauthor #1
Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system.
200571 citationsauthor #6
Beliefs as a predictor of relapse in alcohol-dependent Turkish men.
200514 citationsauthor #4
FUNDING WATCH
20050 citationsauthor #1
The Maximum-likelihood Strategy for Determining Transcranial Magnetic Stimulation Motor Threshold, Using Parameter Estimation by Sequential Testing Is Faster Than Conventional Methods With Similar Precision
2004130 citationsauthor #6
Differential Brain Activity in Alcoholics and Social Drinkers to Alcohol Cues: Relationship to Craving
2004516 citationsauthor #1
Diagnosis and treatment of co-occurring affective disorders and substance use disorders.
200414 citationsauthor #1
Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.
2004149 citationsauthor #1
NEUROIMAGING IN ALCOHOLISM: RELATIONSHIP TO CRAVING.
20040 citationsauthor #1
Recent advances in the pharmacotherapy of alcoholism
200434 citationsauthor #1
The use of divalproex in the treatment of addictive disorders.
20032 citationsauthor #1
A severe case of clonidine dependence and withdrawal.
20033 citationsauthor #2
Complexity changes of the EEG induced by alcohol cue exposure in alcoholics and social drinkers.
200318 citationsauthor #7
Current review of the comorbidity of affective, anxiety, and substance use disorders
200376 citationsauthor #1
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.
200244 citationsauthor #2
The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial
2002174 citationsauthor #2
The use of divalproex in alcohol relapse prevention: a pilot study.
2002115 citationsauthor #2
Clinical characteristics of under-reporters on urine drug screens in a cocaine treatment study.
200216 citationsauthor #1
Gabapentin for misuse of homemade nicotine nasal spray.
20018 citationsauthor #1
New developments in the pharmacotherapy of alcohol dependence.
200155 citationsauthor #1
Gabapentin in the treatment of cocaine dependence: a case series.
200192 citationsauthor #1
Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
200121 citationsauthor #1
Divalproex Loading in the Treatment of Cocaine Dependence
200134 citationsauthor #1
Management of Comorbid Anxiety and Substance Use Disorders
20012 citationsauthor #1
Update on anticonvulsants for the treatment of alcohol withdrawal.
2001118 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT